Inutest
Recall
|
Medicines
|
23/03/2018
The marketing authorization holder has informed its supplied customers in a letter dated 23.03.2018 that increased anaphylactic reactions have been reported after administration of an identical product in France. For this reason, the above mentioned batches are recalled as a precautionary measure.
Name of the medicinal product | Inutest 25 % Ampullen |
---|---|
Marketing authorisation number(s) | 12687 |
Marketing authorisation holder | Fresenius Kabi Austria GmbH |
Batch number(s) | 11144222 |
Classification of the recall | 1 |
BASG reference number | INS-640.001-2496 |
Further inquiry note
Page last modified:
12/07/2022